BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited cardiac disease with reduced penetrance and a highly variable expression. Mutations in the gene encoding the plakophilin-2 gene (PKP2) are detected in about 50% of ARVC/D patients. The p.Arg79X mutation in PKP2 has been identified in Europe and North America and has been functionally characterised. We evaluated the prevalence of the p.Arg79X mutation in PKP2 in the Dutch population. METHODS: Twelve index patients and 41 family members were evaluated in three university hospitals in the Netherlands. The diagnosis of ARVC/D was established according to the recently revised Task Force Criteria. Segregation of the p.Arg79X mutation was studied and haplotypes were reconstructed to determine whether the p.Arg79X mutation was a recurrent or a founder mutation. RESULTS: The p.Arg79X mutation in PKP2 was identified in 12 index patients. Haplotype analysis revealed a shared haplotype among Dutch p.Arg79X mutation carriers, indicating a common founder. Six index patients (50%) had a first- or second-degree relative who had died of sudden cardiac death below 40 years of age. At age 60, only 60% of the mutation carriers had experienced any symptoms. There was no significant difference in symptom-free survival and event-free survival between men and women. CONCLUSION: We have identified the largest series of patients with the same desmosome gene mutation in ARVC/D reported to date. This p.Arg79X mutation in PKP2 is a founder mutation in the Dutch population. The phenotypes of PKP2 p.Arg79X mutation carriers illustrate the clinical variability and reduced penetrance often seen in ARVC/D. (Neth Heart J 2010;18:583-91.).
BACKGROUND:Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited cardiac disease with reduced penetrance and a highly variable expression. Mutations in the gene encoding the plakophilin-2 gene (PKP2) are detected in about 50% of ARVC/D patients. The p.Arg79X mutation in PKP2 has been identified in Europe and North America and has been functionally characterised. We evaluated the prevalence of the p.Arg79X mutation in PKP2 in the Dutch population. METHODS: Twelve index patients and 41 family members were evaluated in three university hospitals in the Netherlands. The diagnosis of ARVC/D was established according to the recently revised Task Force Criteria. Segregation of the p.Arg79X mutation was studied and haplotypes were reconstructed to determine whether the p.Arg79X mutation was a recurrent or a founder mutation. RESULTS: The p.Arg79X mutation in PKP2 was identified in 12 index patients. Haplotype analysis revealed a shared haplotype among Dutch p.Arg79X mutation carriers, indicating a common founder. Six index patients (50%) had a first- or second-degree relative who had died of sudden cardiac death below 40 years of age. At age 60, only 60% of the mutation carriers had experienced any symptoms. There was no significant difference in symptom-free survival and event-free survival between men and women. CONCLUSION: We have identified the largest series of patients with the same desmosome gene mutation in ARVC/D reported to date. This p.Arg79X mutation in PKP2 is a founder mutation in the Dutch population. The phenotypes of PKP2p.Arg79X mutation carriers illustrate the clinical variability and reduced penetrance often seen in ARVC/D. (Neth Heart J 2010;18:583-91.).
Authors: Frank I Marcus; William J McKenna; Duane Sherrill; Cristina Basso; Barbara Bauce; David A Bluemke; Hugh Calkins; Domenico Corrado; Moniek G P J Cox; James P Daubert; Guy Fontaine; Kathleen Gear; Richard Hauer; Andrea Nava; Michael H Picard; Nikos Protonotarios; Jeffrey E Saffitz; Danita M Yoerger Sanborn; Jonathan S Steinberg; Harikrishna Tandri; Gaetano Thiene; Jeffrey A Towbin; Adalena Tsatsopoulou; Thomas Wichter; Wojciech Zareba Journal: Circulation Date: 2010-02-19 Impact factor: 29.690
Authors: Moniek G P J Cox; Jasper J van der Smagt; Maartje Noorman; Ans C Wiesfeld; Paul G A Volders; Irene M van Langen; Douwe E Atsma; Dennis Dooijes; Arjan C Houweling; Peter Loh; Luc Jordaens; Yvonne Arens; Maarten J Cramer; Pieter A Doevendans; J Peter van Tintelen; Arthur A M Wilde; Richard N W Hauer Journal: Circ Arrhythm Electrophysiol Date: 2010-03-09
Authors: Arnd Heuser; Eva R Plovie; Patrick T Ellinor; Katja S Grossmann; Jordan T Shin; Thomas Wichter; Craig T Basson; Bruce B Lerman; Sabine Sasse-Klaassen; Ludwig Thierfelder; Calum A MacRae; Brenda Gerull Journal: Am J Hum Genet Date: 2006-10-03 Impact factor: 11.025
Authors: A Nava; B Bauce; C Basso; M Muriago; A Rampazzo; C Villanova; L Daliento; G Buja; D Corrado; G A Danieli; G Thiene Journal: J Am Coll Cardiol Date: 2000-12 Impact factor: 24.094
Authors: F I Marcus; G H Fontaine; G Guiraudon; R Frank; J L Laurenceau; C Malergue; Y Grosgogeat Journal: Circulation Date: 1982-02 Impact factor: 29.690
Authors: M Shoaib Hamid; Mark Norman; Asifa Quraishi; Sami Firoozi; Rajesh Thaman; Juan R Gimeno; Bhavesh Sachdev; Edward Rowland; Perry M Elliott; William J McKenna Journal: J Am Coll Cardiol Date: 2002-10-16 Impact factor: 24.094
Authors: Wouter P Te Rijdt; Jan Dh Jongbloed; Rudolf A de Boer; Gaetano Thiene; Cristina Basso; Maarten P van den Berg; J Peter van Tintelen Journal: Eur J Hum Genet Date: 2013-06-05 Impact factor: 4.246
Authors: Annukka M Lahtinen; Aki S Havulinna; Peter A Noseworthy; Antti Jula; Pekka J Karhunen; Markus Perola; Christopher Newton-Cheh; Veikko Salomaa; Kimmo Kontula Journal: Ann Med Date: 2013-05-08 Impact factor: 4.709
Authors: Marina Cerrone; Maartje Noorman; Xianming Lin; Halina Chkourko; Feng-Xia Liang; Roel van der Nagel; Thomas Hund; Walter Birchmeier; Peter Mohler; Toon A van Veen; Harold V van Rijen; Mario Delmar Journal: Cardiovasc Res Date: 2012-07-03 Impact factor: 10.787
Authors: P A van der Zwaag; I A W van Rijsingen; R de Ruiter; E A Nannenberg; J A Groeneweg; J G Post; R N W Hauer; I C van Gelder; M P van den Berg; P van der Harst; A A M Wilde; J P van Tintelen Journal: Neth Heart J Date: 2013-06 Impact factor: 2.380
Authors: J A Groeneweg; J F van der Heijden; D Dooijes; T A B van Veen; J P van Tintelen; R N Hauer Journal: Neth Heart J Date: 2014-08 Impact factor: 2.380